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Introduction
Infantile myofibromatosis (IM) is considered the most 
frequent type of mesenchymal tumor in the neonatal 
period and primary infancy [1]. It represents a rare 
disorder of fibroblastic/myofibroblastic proliferation 
with unknown etiology [2]. Three clinical types have 
been described: solitary (most frequent), multicentric 
(involving the skin, subcutaneous tissues, muscles and 
bone), and generalized (with visceral involvement). 
We present a case of multicentric IM in an infant with 
spontaneous regression over time.
Case Synopsis
A 2-month-old female infant was referred to our 
department because of the presence of four 
congenital erythemato-violaceous cutaneous lesions 
localized on the temporal, dorsal, and lumbar regions, 
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Figure 1. Clinical aspect of the lesions: (A-C) initial lesions; (D-F) 
regression of the lesions on follow-up visit after 18 months.
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and lower right leg. The patient was otherwise 
healthy, with normal psychomotor development.
On physical examination, the patient had a linear 
erythemato-violaceous plaque localized to the 
right temporal region of the head (Figure 1A), two 
erythematous nodules on the back (Figure 1B), 
one dorsal and one lumbar, and an erythemato-
violaceous ovoid plaque on the popliteal region of 
the right leg (Figure 1C).
A skin biopsy was performed on both nodules on the 
back revealing bundles and whorls of cytologically 
bland myoid spindle cells with tapering nuclei and 
palely eosinophilic cytoplasm, focally associated with 
delicate thin-walled vascular channels compatible 
with myofibroma (Figure 2A, B). Immunostaining 
was positive for vimentin, smooth muscle actin, 
calponin, and CD 68 (focally), and negative for 
desmin, S100 and EMA (Figure 2, C, D).
A diagnosis of IM was made. Chest radiography and 
abdominal and transfontanelar ultrasound were 
normal and the patient had no clinical signs of visceral 
involvement. On follow-up visit after 18 months the 
lesions had regressed completely leaving residual, 
slightly atrophic violaceous scars (Figure 1, D-F).
Case Discussion
IM was first described in 1954 by Stout, who named 
this entity “congenital generalized fibromatosis” 
[3]. It was only in 1981 that Chung and Enzinger 
introduced the term “infantile myofibromatosis” 
based on histochemical findings that allowed the 
authors to identify cell lines from which the tumor 
arises, further dividing this entity into subgroups 
with distinct prognosis depending on the location 
and involvement (with or without visceral lesions) 
[4]. More recently, IM has been considered to be part 
of a spectrum of tumors with perivascular myoid 
differentiation [5, 6].
The disorder may be present from birth to two years 
of age and rarely occurs in older children and adults 
[7]. Three clinical types have been described. The 
solitary type (most common) presents as a solitary, 
firm, well-circumscribed, and painless nodule, usually 
affecting the skin, muscle, bone and subcutaneous 
tissue in the head, neck, or trunk. The multicentric 
form (as in our case), consists of multiple lesions with 
involvement limited to the skin, subcutaneous tissues, 
muscles, and bone, without visceral involvement. 
The generalized form is defined by skin and visceral 
involvement [8, 9].
The diagnosis must be confirmed by a biopsy of the 
lesion(s). Histologically, there is a proliferation of 
spindle-shaped collagen-forming cells, sometimes 
arranged in whorled or interlacing fascicles. 
Immunohistochemical staining shows characteristics 
between fibroblasts and smooth muscle cells, being 
positive for vimentin and SMA; reactivity for desmin 
is variable [4]. CD-34 antigen has also been reported 
to be positive in cases of infantile myofibromatosis 
with hemangiopericytoma-like pattern [6].
Calponin is considered to be a family of actin filament-
associated proteins expressed in both smooth 
muscle and non-smooth muscle cells [10]. In routine 
biopsy practice, immunohistochemical detection of 
calponin mainly serves to confirm smooth muscle 
and myoepithelial cell differentiation. Monoclonal 
antihuman calponin antibodies stain positively with 
differentiated visceral and vascular smooth muscle 
cells, myoepithelial cells in the lobules, ducts, and 
galactophorous tissue of normal human breasts, as 
well as periacinar and periductal myoepithelial cells 
of the salivary glands. Thus, calponin is expressed not 
only in some mesenchymal neoplasms, but also in 
benign or malignant tumors of myoepithelial origin 
(salivary glands, breast, or skin), [11-14].
Figure 2. Histology and immunohistochemistry: (A) H&E, 100x; 
(B) H&E, 200x; (C) positive immunohistochemistry for smooth 
muscle actin; (D) immunohistochemistry, negative for desmin.
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The prognosis is largely dependent on the presence 
of visceral involvement. Most cases have a benign, 
self-limited course, with spontaneous regression 
being the usual course. However, in cases of visceral 
involvement the prognosis is poor, with mortality 
rates of up to 73% [2, 15, 16].
No treatment is usually necessary for the solitary 
type. Surgical treatment is warranted when vital 
structures are affected, especially in the generalized 
variety. Chemotherapy has also been used with 
some success to treat patients with recurrent or 
nonresectable tumors [17, 18]. Follow-up is essential 
in all patients owing to the possibility of recurrence.
The diagnosis and treatment of IM is challenging 
at times. Thorough histopathological evaluation 
is essential to diagnose these. tumors in early 
infancy and to avoid unnecessary interventions and 
morbidity in these patients.
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